SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
20299497
Source:
http://linkedlifedata.com/resource/pubmed/id/20299497
Search
Subject
(
58
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0006142
,
umls-concept:C0013216
,
umls-concept:C0034802
,
umls-concept:C0086418
,
umls-concept:C0449445
,
umls-concept:C0600558
pubmed:issue
7
pubmed:dateCreated
2010-6-30
pubmed:abstractText
We investigated the pathological effects of neoadjuvant chemotherapy based on the human epidermal growth factor receptor 2 in operable breast cancer.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0313225
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anthracyclines
,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide
,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2
,
http://linkedlifedata.com/resource/pubmed/chemical/Taxoids
,
http://linkedlifedata.com/resource/pubmed/chemical/docetaxel
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1465-3621
pubmed:author
pubmed-author:ChishimaTakashiT
,
pubmed-author:EndoItaruI
,
pubmed-author:IchikawaYasushiY
,
pubmed-author:IshikawaTakashiT
,
pubmed-author:KawachiKaeK
,
pubmed-author:MoritaSatoshiS
,
pubmed-author:NozawaAkinoriA
,
pubmed-author:OtaIkukoI
,
pubmed-author:SasakiTakeshiT
,
pubmed-author:ShimadaHiroshiH
,
pubmed-author:ShimizuDaisukeD
,
pubmed-author:TanabeMikikoM
pubmed:issnType
Electronic
pubmed:volume
40
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
620-6
pubmed:meshHeading
pubmed-meshheading:20299497-Adolescent
,
pubmed-meshheading:20299497-Adult
,
pubmed-meshheading:20299497-Aged
,
pubmed-meshheading:20299497-Anthracyclines
,
pubmed-meshheading:20299497-Antineoplastic Agents
,
pubmed-meshheading:20299497-Breast Neoplasms
,
pubmed-meshheading:20299497-Cyclophosphamide
,
pubmed-meshheading:20299497-Female
,
pubmed-meshheading:20299497-Humans
,
pubmed-meshheading:20299497-Middle Aged
,
pubmed-meshheading:20299497-Neoadjuvant Therapy
,
pubmed-meshheading:20299497-Receptor, erbB-2
,
pubmed-meshheading:20299497-Taxoids
,
pubmed-meshheading:20299497-Young Adult
pubmed:year
2010
pubmed:articleTitle
A human epidermal growth factor receptor 2 expression-based approach to neoadjuvant chemotherapy for operable breast cancer.
pubmed:affiliation
Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Kanagawa, Japan. tishik@urahp.yokohama-cu.ac.jp
pubmed:publicationType
Journal Article
,
Clinical Trial